Mesenchymal Stromal Cells but Not Cardiac Fibroblasts Exert Beneficial Systemic Immunomodulatory Effects in Experimental Myocarditis
Konstantinos Savvatis(St Bartholomew's Hospital), Carsten Tschöpe(Deutsches Herzzentrum der Charité)
Cited by 58
Related Papers
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|716
Inflammation – Cause or Consequence of Heart Failure or Both?
|Current Heart Failure Reports|2017|457
Right Heart Dysfunction and Failure in Heart Failure with Preserved Ejection Fraction: Mechanisms and Management. Position Statement on Behalf of the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2017|380
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
|European Journal of Heart Failure|2023|187